Cannabis stocks soared on reports of Trump easing restrictions, with Curaleaf Holdings leading the rally with 124% YTD gains. Despite mixed Q3 results, revenue reached $320 million, driven by international expansion. The company’s Anthem pre-roll brand saw rapid success, while new products like the ACE extraction oil are gaining traction.

Curaleaf’s innovative QMID vaporizer and strong financials, including $107 million in cash, show its growth potential. Analysts predict revenue to rise from $1.27 billion in 2025 to $1.70 billion in 2029, with stock value potentially tripling. Analysts’ recommendations for CURLF stock are mostly positive, with an average price target of $3.77.

Read more at Yahoo Finance: Want to Jump on the Cannabis Stocks Rally? This Company Has Been the Top-Performing Player in 2025.